{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:48:52Z","timestamp":1790970532043,"version":"4.1.0"},"reference-count":86,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a complex mitochondrial disorder characterized by a wide range of systemic manifestations. Key clinical features include recurrent stroke-like episodes, seizures, lactic acidosis, muscle weakness, exercise intolerance, sensorineural hearing loss, diabetes, and progressive neurological decline. MELAS is most commonly associated with mutations in mitochondrial DNA, particularly the m.3243A&gt;G mutation in the MT-TL1 gene, which encodes tRNALeu (CUR). These mutations impair mitochondrial protein synthesis, leading to defective oxidative phosphorylation and energy failure at the cellular level. The clinical presentation and severity vary widely among patients, but the syndrome often results in significant morbidity and reduced life expectancy because of progressive neurological deterioration. Current management is largely focused on conservative care, including anti-seizure medications, arginine or citrulline supplementation, high-dose taurine, and dietary therapies. However, these therapies do not address the underlying genetic mutations, leaving many patients with substantial disease burden. Emerging experimental treatments, such as gene therapy and mitochondrial replacement techniques, aim to correct the underlying genetic defects and offer potential curative strategies. Further research is essential to understand the pathophysiology of MELAS, optimize current therapies, and develop novel treatments that may significantly improve patient outcomes and extend survival.<\/jats:p>","DOI":"10.3390\/biom14121524","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:19:39Z","timestamp":1732771179000},"page":"1524","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Diagnosis and Management of Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes Syndrome"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3051-2010","authenticated-orcid":false,"given":"Ji-Hoon","family":"Na","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06229, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-249X","authenticated-orcid":false,"given":"Young-Mock","family":"Lee","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06229, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"ref_1","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). MELAS. GeneReviews(\u00ae), University of Washington."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s11011-021-00772-x","article-title":"Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS","volume":"36","author":"Tetsuka","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1212\/WNL.0b013e31823a0c7f","article-title":"Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype","volume":"77","author":"Kaufmann","year":"2011","journal-title":"Neurology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00023210-200620060-00002","article-title":"The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: A review of treatment options","volume":"20","author":"Scaglia","year":"2006","journal-title":"CNS Drugs"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fan, H.C., Lee, H.F., Yue, C.T., and Chi, C.S. (2021). Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. Life, 11.","DOI":"10.3390\/life11111111"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"Adesina","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/S0140-6736(18)30727-X","article-title":"Mitochondrial medicine in the omics era","volume":"391","author":"Rahman","year":"2018","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nusir, A., Sinclair, P., and Kabbani, N. (2023). Mitochondrial Proteomes in Neural Cells: A Systematic Review. Biomolecules, 13.","DOI":"10.3390\/biom13111638"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, D., Liang, C., Zhang, T., Marley, J.L., Zou, W., Lian, M., and Ji, D. (2022). Pathogenic mitochondrial DNA 3243A>G mutation: From genetics to phenotype. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.951185"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature18902","article-title":"Genetics: Mitochondrial DNA in evolution and disease","volume":"535","author":"Wallace","year":"2016","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/s41588-024-01794-8","article-title":"Mitochondrial genetics through the lens of single-cell multi-omics","volume":"56","author":"Nitsch","year":"2024","journal-title":"Nat. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cox, B.C., Pearson, J.Y., Mandrekar, J., and Gavrilova, R.H. (2023). The clinical spectrum of MELAS and associated disorders across ages: A retrospective cohort study. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1298569"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(21)00098-3","article-title":"Mitochondrial disease in adults: Recent advances and future promise","volume":"20","author":"Ng","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/acn3.532","article-title":"Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors","volume":"5","author":"Pickett","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Barros, C.D.S., Coutinho, A., and Tengan, C.H. (2024). Arginine Supplementation in MELAS Syndrome: What Do We Know about the Mechanisms?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073629"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zheng, H., Zhang, X., Tian, L., Liu, B., He, X., Wang, L., Ding, S., Guo, Y., and Cai, J. (2022). Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with an MT-TL1 m.3243A>G point mutation: Neuroradiological features and their implications for underlying pathogenesis. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.1028762"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Scholle, L.M., Zierz, S., Mawrin, C., Wickenhauser, C., and Urban, D.L. (2020). Heteroplasmy and Copy Number in the Common m.3243A>G Mutation-A Post-Mortem Genotype-Phenotype Analysis. Genes, 11.","DOI":"10.3390\/genes11020212"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41439-018-0026-6","article-title":"Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome","volume":"5","author":"Ikeda","year":"2018","journal-title":"Hum. Genome Var."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s00415-020-10390-9","article-title":"Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome","volume":"268","author":"Chakrabarty","year":"2021","journal-title":"J. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bedkowska, N., Zontek, A., and Paprocka, J. (2022). Stroke-like Episodes in Inherited Neurometabolic Disorders. Metabolites, 12.","DOI":"10.3390\/metabo12100929"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lin, W.-H., Yang, I.H., Cheng, H.-E., and Lin, H.-F. (2022). Case Report: Late-Onset Mitochondrial Disease Uncovered by Metformin Use in a Patient with Acute Verbal Auditory Agnosia. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.863047"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s10072-024-07343-9","article-title":"A case of exacerbated encephalopathy with stroke-like episodes and lactic acidosis triggered by metformin in a patient with MELAS","volume":"45","author":"Shin","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/brain\/awab353","article-title":"Forecasting stroke-like episodes and outcomes in mitochondrial disease","volume":"145","author":"Ng","year":"2022","journal-title":"Brain"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2019.03.021","article-title":"Mitochondrial metabolic stroke: Phenotype and genetics of stroke-like episodes","volume":"400","author":"Finsterer","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1955","DOI":"10.1002\/mgg3.1955","article-title":"Molecular and neurological features of MELAS syndrome in paediatric patients: A case series and review of the literature","volume":"10","author":"Seed","year":"2022","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00415-019-09283-3","article-title":"A cluster of disseminated small cortical lesions in MELAS: Its distinctive clinical and neuroimaging features","volume":"266","author":"Hongo","year":"2019","journal-title":"J. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lopriore, P., Gomes, F., Montano, V., Siciliano, G., and Mancuso, M. (2022). Mitochondrial Epilepsy, a Challenge for Neurologists. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113216"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Oyama, M., Iizuka, T., Nakahara, J., and Izawa, Y. (2020). Neuroimaging pattern and pathophysiology of cerebellar stroke-like lesions in MELAS with m.3243A>G mutation: A case report. BMC Neurol., 20.","DOI":"10.1186\/s12883-020-01748-7"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Riquin, E., Duverger, P., Cariou, C., Barth, M., Prouteau, C., Van Bogaert, P., Bonneau, D., and Roy, A. (2020). Neuropsychological and Psychiatric Features of Children and Adolescents Affected with Mitochondrial Diseases: A Systematic Review. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00747"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ddr.21294","article-title":"Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases","volume":"77","author":"Irwin","year":"2016","journal-title":"Drug Dev. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mito.2023.08.002","article-title":"Epilepsy: Mitochondrial connections to the \u2018Sacred\u2019 disease","volume":"72","author":"Moos","year":"2023","journal-title":"Mitochondrion"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ddr.21295","article-title":"Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia","volume":"77","author":"Moos","year":"2016","journal-title":"Drug Dev. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4088\/JCP.11r07237","article-title":"The psychiatric manifestations of mitochondrial disorders: A case and review of the literature","volume":"73","author":"Anglin","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2011.04.004","article-title":"Mitochondrial dysfunction in epilepsy","volume":"12","author":"Folbergrova","year":"2012","journal-title":"Mitochondrion"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Fine, A.L., Liebo, G., Gavrilova, R.H., and Britton, J.W. (2021). Seizure Semiology, EEG, and Imaging Findings in Epilepsy Secondary to Mitochondrial Disease. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.779052"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1016\/j.radcr.2024.08.159","article-title":"Moyamoya syndrome secondary to MELAS syndrome in a child: A case report and literature revue","volume":"19","author":"Benbrahim","year":"2024","journal-title":"Radiol. Case Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e000825","DOI":"10.1136\/bmjno-2024-000825","article-title":"Neurological manifestations in adult patients with the m.3243A>G variant in mitochondrial DNA","volume":"6","author":"Majamaa","year":"2024","journal-title":"BMJ Neurol. Open"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mito.2021.11.006","article-title":"Phenotypes and genotypes of mitochondrial diseases with mtDNA variations in Chinese children: A multi-center study","volume":"62","author":"Shi","year":"2022","journal-title":"Mitochondrion"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10741-015-9524-5","article-title":"MELAS syndrome and cardiomyopathy: Linking mitochondrial function to heart failure pathogenesis","volume":"21","author":"Hsu","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jimd.12195","article-title":"A high prevalence of arterial hypertension in patients with mitochondrial diseases","volume":"43","author":"Stalens","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3174\/ajnr.A7837","article-title":"MELAS: Phenotype Classification into Classic-versus-Atypical Presentations","volume":"44","author":"Alves","year":"2023","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"102523","DOI":"10.1016\/j.jaccas.2024.102523","article-title":"Successful Simultaneous Heart-Kidney Transplant in a Patient With MT-TL1 MELAS Cardiomyopathy","volume":"29","author":"Mutschler","year":"2024","journal-title":"JACC Case Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5414\/CN107063","article-title":"Renal involvement in MELAS syndrome\u2014A series of 5 cases and review of the literature","volume":"80","author":"Seidowsky","year":"2013","journal-title":"Clin. Nephrol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4093\/dmj.2023.0078","article-title":"Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea","volume":"48","author":"Rho","year":"2024","journal-title":"Diabetes Metab. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/EJE-20-0189","article-title":"Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS syndrome","volume":"183","author":"Chae","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0960-8966(92)90045-8","article-title":"Melas: An original case and clinical criteria for diagnosis","volume":"2","author":"Hirano","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: A nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","first-page":"e24746","article-title":"Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes\/Leigh Overlap Syndrome Due to Variant m.13513G>A in MT-ND5","volume":"14","author":"Finsterer","year":"2022","journal-title":"Cureus"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/jmg.2005.034140","article-title":"Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: Contribution to understanding mitochondrial DNA segregation during human embryofetal development","volume":"43","author":"Bouchet","year":"2006","journal-title":"J. Med. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11916-016-0583-7","article-title":"Imaging of MELAS","volume":"20","author":"Malhotra","year":"2016","journal-title":"Curr. Pain. Headache Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/ane.13027","article-title":"MELAS: Monitoring treatment with magnetic resonance spectroscopy","volume":"139","author":"Hovsepian","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Tragni, V., Primiano, G., Tummolo, A., Cafferati Beltrame, L., La Piana, G., Sgobba, M.N., Cavalluzzi, M.M., Paterno, G., Gorgoglione, R., and Volpicella, M. (2022). Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs. Molecules, 27.","DOI":"10.3390\/molecules27113494"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pediatrneurol.2015.12.010","article-title":"Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report and Critical Reappraisal of Treatment Options","volume":"56","author":"Fryer","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"106546","DOI":"10.1016\/j.yebeh.2019.106546","article-title":"Advances in the treatment of mitochondrial epilepsies","volume":"101","author":"Rahman","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13023-021-01927-w","article-title":"Ketogenic diet for mitochondrial disease: A systematic review on efficacy and safety","volume":"16","author":"Zweers","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp-2018-317964","article-title":"Taurine supplementation for prevention of stroke-like episodes in MELAS: A multicentre, open-label, 52-week phase III trial","volume":"90","author":"Ohsawa","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbagen.2011.04.018","article-title":"In vivo functional brain imaging and a therapeutic trial of L-arginine in MELAS patients","volume":"1820","author":"Yoneda","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2012.06.018","article-title":"Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders","volume":"107","author":"Emrick","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mgene.2013.09.001","article-title":"The effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome","volume":"1","author":"Emrick","year":"2013","journal-title":"Meta Gene"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biocel.2013.12.009","article-title":"Mitochondria: Role of citrulline and arginine supplementation in MELAS syndrome","volume":"48","author":"Emrick","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3945\/jn.117.248435","article-title":"Assessment of Nitric Oxide Production in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome with the Use of a Stable Isotope Tracer Infusion Technique","volume":"147","author":"Jahoor","year":"2017","journal-title":"J. Nutr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40272-020-00384-5","article-title":"Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review","volume":"22","author":"Rashid","year":"2020","journal-title":"Paediatr. Drugs"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10528-017-9807-8","article-title":"The Effect of Citrulline\/Malate on Blood Lactate Levels in Intensive Exercise","volume":"55","author":"Kiyici","year":"2017","journal-title":"Biochem. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Allerton, T.D., Proctor, D.N., Stephens, J.M., Dugas, T.R., Spielmann, G., and Irving, B.A. (2018). l-Citrulline Supplementation: Impact on Cardiometabolic Health. Nutrients, 10.","DOI":"10.3390\/nu10070921"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13256-019-2255-9","article-title":"Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: A case report","volume":"13","author":"Fukuda","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"El-Hattab, A.W., Almannai, M., and Scaglia, F. (2017). Arginine and Citrulline for the Treatment of MELAS Syndrome. J. Inborn Errors Metab. Screen., 5.","DOI":"10.1177\/2326409817697399"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Jong, C.J., Sandal, P., and Schaffer, S.W. (2021). The Role of Taurine in Mitochondria Health: More Than Just an Antioxidant. Molecules, 26.","DOI":"10.3390\/molecules26164913"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00726-012-1414-8","article-title":"Role of taurine in the pathologies of MELAS and MERRF","volume":"46","author":"Schaffer","year":"2014","journal-title":"Amino Acids"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4062\/biomolther.2017.251","article-title":"Effects and Mechanisms of Taurine as a Therapeutic Agent","volume":"26","author":"Schaffer","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Jakaria, M., Azam, S., Haque, M.E., Jo, S.H., Uddin, M.S., Kim, I.S., and Choi, D.K. (2019). Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox Biol., 24.","DOI":"10.1016\/j.redox.2019.101223"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Homma, K., Toda, E., Osada, H., Nagai, N., Era, T., Tsubota, K., Okano, H., and Ozawa, Y. (2021). Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium. Redox Biol., 41.","DOI":"10.1016\/j.redox.2021.101921"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Huang, L., Li, H., Zhong, J., Yang, L., Chen, G., Wang, D., Zheng, G., Han, H., Han, X., and Long, Y. (2022). Efficacy and Safety of the Ketogenic Diet for Mitochondrial Disease with Epilepsy: A Prospective, Open-labeled, Controlled Study. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.880944"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1756286419897813","DOI":"10.1177\/1756286419897813","article-title":"Effective and safe diet therapies for Lennox-Gastaut syndrome with mitochondrial dysfunction","volume":"13","author":"Na","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Belal, S., Gouden\u00e8ge, D., Bocca, C., Dumont, F., Chao De La Barca, J.M., Desquiret-Dumas, V., Gueguen, N., Geffroy, G., Benyahia, R., and Kane, S. (2022). Glutamate-Induced Deregulation of Krebs Cycle in Mitochondrial Encephalopathy Lactic Acidosis Syndrome Stroke-Like Episodes (MELAS) Syndrome Is Alleviated by Ketone Body Exposure. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071665"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/cns.14274","article-title":"Long-term ketogenic diet therapy improves mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS): A case report","volume":"29","author":"He","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamapediatrics.2022.5648","article-title":"Efficacy and Safety of Dietary Therapies for Childhood Drug-Resistant Epilepsy","volume":"177","author":"Devi","year":"2023","journal-title":"JAMA Pediatr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamapediatrics.2020.2282","article-title":"Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children with Drug-Resistant Epilepsy: A Randomized Clinical Trial","volume":"174","author":"Sondhi","year":"2020","journal-title":"JAMA Pediatr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pediatrneurol.2014.01.009","article-title":"Mitochondrial Encephalopathy with Lactic Acidosis and Stroke-like Episodes (MELAS) May Respond to Adjunctive Ketogenic Diet","volume":"50","author":"Steriade","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Borowicz-Reutt, K., Krawczyk, M., and Czernia, J. (2024). Ketogenic Diet in the Treatment of Epilepsy. Nutrients, 16.","DOI":"10.3390\/nu16091258"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"D\u2019Amato, M., Morra, F., Di Meo, I., and Tiranti, V. (2023). Mitochondrial Transplantation in Mitochondrial Medicine: Current Challenges and Future Perspectives. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24031969"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6687185","DOI":"10.1155\/2020\/6687185","article-title":"Antioxidants Targeting Mitochondrial Oxidative Stress: Promising Neuroprotectants for Epilepsy","volume":"2020","author":"Yang","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Melas, P.A., Scherma, M., Fratta, W., Cifani, C., and Fadda, P. (2021). Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041863"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Si, J., Sun, L., Qin, Y., Peng, L., Gong, Y., Gao, C., Shen, W., and Li, M. (2024). Cannabinoids improve mitochondrial function in skeletal muscle of exhaustive exercise training rats by inhibiting mitophagy through the PINK1\/PARKIN and BNIP3 pathways. Chem.-Biol. Interact., 389.","DOI":"10.1016\/j.cbi.2024.110855"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/EBC20170114","article-title":"Emerging therapies for mitochondrial diseases","volume":"62","author":"Hirano","year":"2018","journal-title":"Essays Biochem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"107180","DOI":"10.1016\/j.phrs.2024.107180","article-title":"Hydrogen sulfide supplementation as a potential treatment for primary mitochondrial diseases","volume":"203","author":"Slade","year":"2024","journal-title":"Pharmacol. Res."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/12\/1524\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:41:31Z","timestamp":1760114491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/12\/1524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":86,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["biom14121524"],"URL":"https:\/\/doi.org\/10.3390\/biom14121524","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}